FDA Inspection 1161167 — CFP Acquisitions Inc.

CFP Acquisitions Inc. — FEI 3001576820

The FDA completed an inspection of CFP Acquisitions Inc. on Jan 18, 2022 in Tulsa, OK. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Jan 18, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tulsa, OK (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.